Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 572

Sort by

Sort Order Select

Journal Articles

CRISPR-Cas13d functional transcriptomics reveals widespread isoform-selective cancer dependencies on lncRNAs

Blood (2025) 146 (7): 847–860.

https://doi.org/10.1182/blood.2025028746

Published: 2025

Includes: Supplemental data

Journal Articles

IL-11 Signaling Drives Clonal Hematopoiesis-Associated Cardiac Dysfunction

Venkatasubramaniam Sundaramurthy, Yue Yuan, Liting Liu, Art Schuermans, Seyedmohammad Saadatagah, Zhi Yu, Alejandra G Martell, Xiaoyan Zhang, Jia Song, Christie M. Ballantyne, Michael C Honigberg, Pradeep Natarajan, Na Li, Margaret Goodell

Blood (2024) 144 (Supplement 1): 948.

https://doi.org/10.1182/blood-2024-208008

Published: 2024

Journal Articles

Tigit: The Potential Mechanisms of Relapse in Multiple Myeloma Following Anti-BCMA CAR-T Therapy and a Promising Target for Improving CAR-T Efficacy

Yuan Xia, Xuxing Shen, Min Shi, Na Shen, Yu Zhu, Lei Fan, Jianyong Li, Lijuan Chen

Blood (2024) 144 (Supplement 1): 2033.

https://doi.org/10.1182/blood-2024-205126

Published: 2024

Journal Articles

Utilization of Therapy-Naïve T Cells to Enhance the Efficacy of CAR-T Cells in the Treatment of B-NHL Patients

Charlotte Junkuhn, Phillip Schiele, David Busch, Julia Polansky-Biskup, Annette Künkele-Langer, Benedikt Obermayer, Lars Bullinger, Marco Frentsch, Il-Kang Na

Blood (2024) 144 (Supplement 1): 2027.

https://doi.org/10.1182/blood-2024-199124

Published: 2024

Journal Articles

Osteoblast-Derived Erythroferrone Regulates Stress Erythropoiesis

Pinanong Na Phatthalung, Yelena Ginzburg, Gabrielle van Caloen, Marina Planoutene, Anisa A. Gumerova, Ronit Witztum, Eva Ingber, Farhath Sultana, Funda Korkmaz, Maayan Levy, Tony Yuen, Mone Zaidi

Blood (2024) 144 (Supplement 1): 2470.

https://doi.org/10.1182/blood-2024-203624

Published: 2024

Journal Articles

Development and Validation of a Machine Learning-Based Early Warning System for Predicting Venous Thromboembolism Risk in Hospitalized Lymphoma Patients Undergoing Chemotherapy: A Multicentre, Retrospective Cohort Study

Tingting Jiang, Zailin Yang, Xinyi Tang, Yakun Zhang, Shuang Chen, Yu Peng, Xiaomei Zhang, Li Jun, Bingling Guo, Jieping Li, Tingting Liu, Haike Lei, Zuhai Hu, Na Fang, Xia Wei, Xuefen Liu, Yong Chen, Yao Liu

Blood (2024) 144 (Supplement 1): 1259.

https://doi.org/10.1182/blood-2024-206307

Published: 2024

Journal Articles

TMPRSS6 Antisense Oligonucleotide Therapy Reverses Inflammation in Jak2 V617F Mutant Mice

Maayan Levy, Huihui Li, Andrew Dunbar, Zixing Huang, Young Park, Min Lu, Pinanong Na Phattalung, Marina Planoutene, Carla Casu, Stefano Rivella, Shuling Guo, Ross L Levine, Ronald Hoffman, Yelena Ginzburg

Blood (2024) 144 (Supplement 1): 8.

https://doi.org/10.1182/blood-2024-203806

Published: 2024

Journal Articles

A Novel Small Molecule Drug-Based Approach for Treating Beta-Globinopathies

Jun Liu, Ziyang Shen, Yanhua Dong, Na Yu, Li Chai, Daniel G. Tenen, Daniel E. Bauer, Adelaide Herman, Braden Pate, Kim Vanuytsel

Blood (2024) 144 (Supplement 1): 172.

https://doi.org/10.1182/blood-2024-211753

Published: 2024

Journal Articles

Olverembatinib As Second-Line (2L) Therapy in Patients (pts) with Chronic Phase-Chronic Myeloid Leukemia (CP-CML)

Li Weiming, Yanli Zhang, Huanling Zhu, Yunfan Yang, Na Xu, Bingcheng Liu, Zi Chen, Wei Chu, Yifan Zhai, Yu Hu

Blood (2024) 144 (Supplement 1): 480.

https://doi.org/10.1182/blood-2024-204996

Published: 2024

Journal Articles

CD33 Antibody-Modified Nanoparticles Encapsulated IL-15 Induce ISG15 to Promote MHC I Expression in Leukemia Cells Via Innate Immunity Pathway Inducing Graft-Versus-Leukemia without Aggravating Graft-Versus-Host Disease

Ruowen Wei, Ao Zhang, Moran Wang, Xie-Na Cao, Ruiqi Zhu, Shengling Ma, Linghui Xia, Wei Shi

Blood (2024) 144 (Supplement 1): 904.

https://doi.org/10.1182/blood-2024-200551

Published: 2024

Journal Articles

Addition of Daclizumab to Standard Graft-Versus-Host Disease Prophylaxis in Patients with Thalassemia Major Undergoing Transplantation from Alternative Donor Hematopoietic Stem-Cell Transplantation: A Single-Center Retrospective Analysis from China

Blood (2024) 144 (Supplement 1): 2152.

https://doi.org/10.1182/blood-2024-205021

Published: 2024

Journal Articles

CD123-CAR T Cells Manufactured in the Presence of Dasatinib Induce High Grade CRS and/or IEC-HS without Improving Efficacy in Pediatric Patients with Recurrent/Refractory Leukemia

Blood (2024) 144 (Supplement 1): 2076.

https://doi.org/10.1182/blood-2024-208795

Published: 2024

Journal Articles

Cytogenetic Abnormalities Following CAR T Cell Therapy for B-Cell Malignancies

Na Hyun Kim, Fatima Khamissi, Kathleen Bone, Nathan Kopp, Walter Longo, Bryon D. Johnson, Tyce Kearl, Peiman Hematti, Mehdi Hamadani, Timothy S. Fenske, Nirav N. Shah

Blood (2024) 144 (Supplement 1): 3459.

https://doi.org/10.1182/blood-2024-205752

Published: 2024

Journal Articles

Comparison of the Efficacy and Adverse Effects of Recipient-Derived Versus Donor-Derived CAR-T Cell Therapy for Post-Transplant Relapse in B-ALL

Lichao Liu, Ruihao Huang, Yongxian Hu, Sanfang Tu, Na Wang, Hai Yi, Qiuying Gao, Jian Zhou, Xiaoqi Wang, Cheng Zhang, Xi Zhang

Blood (2024) 144 (Supplement 1): 3469.

https://doi.org/10.1182/blood-2024-207676

Published: 2024

Journal Articles

Analysis of the Impact of TKI Dose Adjustment Under the Guidance of Blood Concentration Monitoring on the Efficacy, Safety and Quality of Life in Patients with CML

Zherou He, Qing Zhang, Xuan Zhou, Qiang Wang, Xiaoli Liu, Na Xu

Blood (2024) 144 (Supplement 1): 1773.

https://doi.org/10.1182/blood-2024-207302

Published: 2024

Journal Articles

Treatment Outcomes for Patients with TP53 -Mutated Mantle Cell Lymphoma: A Systematic Review and Meta-Analysis

Na Zhang, Jiegang Xu, Chengxin Luo, Dongfeng Zeng, Shuangnian Xu, Xi Li

Blood (2024) 144 (Supplement 1): 3041.

https://doi.org/10.1182/blood-2024-209480

Published: 2024

Journal Articles

Post Hoc Analysis of Phase III Gecacitinib Clinical Trial Outcomes: Enhanced Understanding and Implications

Blood (2024) 144 (Supplement 1): 3165.

https://doi.org/10.1182/blood-2024-202790

Published: 2024

Journal Articles

The Efficacy and Safety of Selinexor Plus Ruxolitinib Regimen in Ruxolitinib-Resistant Myelofibrosis: A Retrospective Study

Ziyu Wen, Xuan Zhou, Bingyu Lin, Xiaoli Liu, Qiang Wang, Na Xu

Blood (2024) 144 (Supplement 1): 1803.

https://doi.org/10.1182/blood-2024-205725

Published: 2024

Journal Articles

Higher NOTCH1 Mutation Load Reveals Favorable Prognosis in Pediatric T-Cell Acute Lymphoblastic Leukemia

Senlin Zhang, Qi Ji, Zhiqi Zhang, Ping Chen, Xinran Chu, Na Meng, Xiao Zhang, Wei Gao, Minyuan Liu, Yu Liu, Shaoyan Hu

Blood (2024) 144 (Supplement 1): 5927.

https://doi.org/10.1182/blood-2024-210747

Published: 2024

Journal Articles

PC-002 (Sepantronium Bromide) Enhances the Antitumor Efficacy of Anti-CD20 Antibody By CD20 Upregulation

Vernon Jiang, Xiang LI, Na He, Yan Lv, Haiyue Wang, Ming Zhang, Heiyan Zhai, Zhen Yang, Yi Yang, Dagang Guo, Zhixiang Cao, Yiyou Chen

Blood (2024) 144 (Supplement 1): 5822.

https://doi.org/10.1182/blood-2024-209648

Published: 2024

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

CRISPR-Cas13d functional transcriptomics reveals widespread isoform-selective cancer dependencies on lncRNAs

IL-11 Signaling Drives Clonal Hematopoiesis-Associated Cardiac Dysfunction

Tigit: The Potential Mechanisms of Relapse in Multiple Myeloma Following Anti-BCMA CAR-T Therapy and a Promising Target for Improving CAR-T Efficacy

Utilization of Therapy-Naïve T Cells to Enhance the Efficacy of CAR-T Cells in the Treatment of B-NHL Patients

Osteoblast-Derived Erythroferrone Regulates Stress Erythropoiesis

Development and Validation of a Machine Learning-Based Early Warning System for Predicting Venous Thromboembolism Risk in Hospitalized Lymphoma Patients Undergoing Chemotherapy: A Multicentre, Retrospective Cohort Study

TMPRSS6 Antisense Oligonucleotide Therapy Reverses Inflammation in Jak2 V617F Mutant Mice

A Novel Small Molecule Drug-Based Approach for Treating Beta-Globinopathies

Olverembatinib As Second-Line (2L) Therapy in Patients (pts) with Chronic Phase-Chronic Myeloid Leukemia (CP-CML)

CD33 Antibody-Modified Nanoparticles Encapsulated IL-15 Induce ISG15 to Promote MHC I Expression in Leukemia Cells Via Innate Immunity Pathway Inducing Graft-Versus-Leukemia without Aggravating Graft-Versus-Host Disease

Addition of Daclizumab to Standard Graft-Versus-Host Disease Prophylaxis in Patients with Thalassemia Major Undergoing Transplantation from Alternative Donor Hematopoietic Stem-Cell Transplantation: A Single-Center Retrospective Analysis from China

CD123-CAR T Cells Manufactured in the Presence of Dasatinib Induce High Grade CRS and/or IEC-HS without Improving Efficacy in Pediatric Patients with Recurrent/Refractory Leukemia

Cytogenetic Abnormalities Following CAR T Cell Therapy for B-Cell Malignancies

Comparison of the Efficacy and Adverse Effects of Recipient-Derived Versus Donor-Derived CAR-T Cell Therapy for Post-Transplant Relapse in B-ALL

Analysis of the Impact of TKI Dose Adjustment Under the Guidance of Blood Concentration Monitoring on the Efficacy, Safety and Quality of Life in Patients with CML

Treatment Outcomes for Patients with TP53 -Mutated Mantle Cell Lymphoma: A Systematic Review and Meta-Analysis

Post Hoc Analysis of Phase III Gecacitinib Clinical Trial Outcomes: Enhanced Understanding and Implications

The Efficacy and Safety of Selinexor Plus Ruxolitinib Regimen in Ruxolitinib-Resistant Myelofibrosis: A Retrospective Study

Higher NOTCH1 Mutation Load Reveals Favorable Prognosis in Pediatric T-Cell Acute Lymphoblastic Leukemia

PC-002 (Sepantronium Bromide) Enhances the Antitumor Efficacy of Anti-CD20 Antibody By CD20 Upregulation

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only